Western Blot (WB)
(TRNT1 antibody (MBS5300157) used at 2.5 ug/ml to detect target protein.)
Rabbit TRNT1 Polyclonal Antibody | anti-TRNT1 antibody
TRNT1 antibody
IHC: 16 ug/ml
Western Blot (WB)
(TRNT1 antibody (MBS5300157) used at 2.5 ug/ml to detect target protein.)
Western Blot (WB)
(TRNT1 antibody (MBS5300157) used at 2.5 ug/ml to detect target protein.)
NCBI and Uniprot Product Information
NCBI Description
The protein encoded by this gene is a CCA-adding enzyme which belongs to the tRNA nucleotidyltransferase/poly(A) polymerase family. This essential enzyme functions by catalyzing the addition of the conserved nucleotide triplet CCA to the 3' terminus of tRNA molecules. Mutations in this gene result in sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
Uniprot Description
TRNT1: Isoform 1: Adds and repairs the conserved 3'-CCA sequence necessary for the attachment of amino acids to the 3' terminus of tRNA molecules, using CTP and ATP as substrates. Belongs to the tRNA nucleotidyltransferase/poly(A) polymerase family. 3 isoforms of the human protein are produced by alternative splicing.
Protein type: Mitochondrial; Transferase; EC 2.7.7.72; RNA processing
Chromosomal Location of Human Ortholog: 3p25.1
Cellular Component: mitochondrion; intracellular
Molecular Function: tRNA adenylyltransferase activity; ATP binding; tRNA binding
Biological Process: tRNA 3'-terminal CCA addition; tRNA 3'-end processing; protein targeting to mitochondrion
Disease: Sideroblastic Anemia With B-cell Immunodeficiency, Periodic Fevers, And Developmental Delay
Research Articles on TRNT1
Similar Products
Product Notes
The TRNT1 trnt1 (Catalog #AAA5300157) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. AAA Biotech's TRNT1 can be used in a range of immunoassay formats including, but not limited to, Western Blot (WB), Immunohistochemistry (IHC). WB: 2.5 ug/ml IHC: 16 ug/ml. Researchers should empirically determine the suitability of the TRNT1 trnt1 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process. It is sometimes possible for the material contained within the vial of "TRNT1, Polyclonal Antibody" to become dispersed throughout the inside of the vial, particularly around the seal of said vial, during shipment and storage. We always suggest centrifuging these vials to consolidate all of the liquid away from the lid and to the bottom of the vial prior to opening. Please be advised that certain products may require dry ice for shipping and that, if this is the case, an additional dry ice fee may also be required.Precautions
All products in the AAA Biotech catalog are strictly for research-use only, and are absolutely not suitable for use in any sort of medical, therapeutic, prophylactic, in-vivo, or diagnostic capacity. By purchasing a product from AAA Biotech, you are explicitly certifying that said products will be properly tested and used in line with industry standard. AAA Biotech and its authorized distribution partners reserve the right to refuse to fulfill any order if we have any indication that a purchaser may be intending to use a product outside of our accepted criteria.Disclaimer
Though we do strive to guarantee the information represented in this datasheet, AAA Biotech cannot be held responsible for any oversights or imprecisions. AAA Biotech reserves the right to adjust any aspect of this datasheet at any time and without notice. It is the responsibility of the customer to inform AAA Biotech of any product performance issues observed or experienced within 30 days of receipt of said product. To see additional details on this or any of our other policies, please see our Terms & Conditions page.Item has been added to Shopping Cart
If you are ready to order, navigate to Shopping Cart and get ready to checkout.
